APA

Schmitz-Dräger B. J., Todenhöfer T., van Rhijn B., Pesch B., Hudson M. A., Chandra A., Ingersoll M. A., Kassouf W., Palou J., Taylor J., Vlahou A., Behrens T., Critelli R., Grossman H. B., Sanchez-Carbayo M. & Kamat A. (20150731). Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer. : Urologic oncology.

Chicago

Schmitz-Dräger Bernd J, Todenhöfer Tilman, van Rhijn Bas, Pesch Beate, Hudson Mĺiss A, Chandra Ashish, Ingersoll Molly A, Kassouf Wassim, Palou Joan, Taylor John, Vlahou Antonia, Behrens Thomas, Critelli Rossana, Grossman H Barton, Sanchez-Carbayo Marta and Kamat Ashish. 20150731. Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer. : Urologic oncology.

Harvard

Schmitz-Dräger B. J., Todenhöfer T., van Rhijn B., Pesch B., Hudson M. A., Chandra A., Ingersoll M. A., Kassouf W., Palou J., Taylor J., Vlahou A., Behrens T., Critelli R., Grossman H. B., Sanchez-Carbayo M. and Kamat A. (20150731). Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer. : Urologic oncology.

MLA

Schmitz-Dräger Bernd J, Todenhöfer Tilman, van Rhijn Bas, Pesch Beate, Hudson Mĺiss A, Chandra Ashish, Ingersoll Molly A, Kassouf Wassim, Palou Joan, Taylor John, Vlahou Antonia, Behrens Thomas, Critelli Rossana, Grossman H Barton, Sanchez-Carbayo Marta and Kamat Ashish. Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer. : Urologic oncology. 20150731.